To describe the outcomes of the surgical intervention, frequencies and percentages were used for the categorical variables.
For implementation: predict the glycemic outcome of a clinical intervention during a relevant 1- to 4-hour timeframe typical of TGC intervention frequencies [24, 38, 46, 47, 49, 50, 71, 72].
Effects of combined intervention were moderated by age of participants, intervention frequency and setting.
Particularly for subsea wells, anything that can reduce the well intervention frequency is usually justifiable.
Participants were randomly assigned to two levels of intervention frequency matched for intervention content (low frequency n = 92, high frequency n = 102).
Due to significant between-study variation for the intervention frequency and duration, we were unable to stratify meta-analyses in this way.
On multivariate analysis, global improvement in the placebo group was associated significantly with intervention frequency (P =.0079), overall treatment response (P =.0031), and parallel study design (P =.0044).
A standardized data extraction form was used to collect data on participants' characteristics (age, gender, and zygosity), sample size, prescribed PA intervention (frequency, intensity, duration, and type), co-prescription of other interventions (e.g., diet), outcomes assessed, loss to follow up, and study type.
For dose, duration of the intervention, frequency of administration and route of administration, information was present in 512 (70.5%), 508 (70.0%), 550 (75.8%) and 535 (73.7%) arms respectively.
For each intervention and active comparator the presence or absence of the following five intervention specifics was collected: name, dose, duration of the intervention, frequency of administration and route of administration.
The frequency of serious AEs (SAEs) requiring intervention frequency of SAEs requiring intervention is <1%.
